Armata Pharmaceuticals, Inc.(ARMP)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Armata Pharmaceuticals, Inc. (ARMP) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ARMP is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), Armata Pharmaceuticals, Inc. reports net income of $74.1M, free cash flow of $-8.7M. Top institutional holders of ARMP by reported 13-F value include Madison Asset Management, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ARMP trades on the NYSE exchange and files with the SEC under CIK 921114. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ARMP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Armata Pharmaceuticals, Inc. directly from SEC EDGAR.